New 'Smart Bomb' drug targets Hard-to-Treat cancers
Disease control
Not yet recruiting
This study is testing a new drug called LCB02A for people with advanced solid tumors that have a specific protein marker called CLDN18.2. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. It is for people whose cancer has not responded…
Phase: PHASE1, PHASE2 • Sponsor: LigaChem Biosciences, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC